Clinical Development of Respiratory Syncytial Virus Antivirals-What We Can Learn From Oseltamivir
- PMID: 31915814
- DOI: 10.1093/cid/ciz1169
Clinical Development of Respiratory Syncytial Virus Antivirals-What We Can Learn From Oseltamivir
Keywords: respiratory syncytial virus; antiviral; clinical trial; human-challenge study.
Comment on
-
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial of Presatovir for the Treatment of Respiratory Syncytial Virus Upper Respiratory Tract Infection in Hematopoietic-Cell Transplant Recipients.Clin Infect Dis. 2020 Dec 31;71(11):2777-2786. doi: 10.1093/cid/ciz1166. Clin Infect Dis. 2020. PMID: 31793991 Free PMC article. Clinical Trial.
-
A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract.Clin Infect Dis. 2020 Dec 31;71(11):2787-2795. doi: 10.1093/cid/ciz1167. Clin Infect Dis. 2020. PMID: 31915807 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
